{"id":"W2914573001","doi":"10.1200/jco.2019.37.4_suppl.635","title":"Nivolumab (NIVO) + low-dose ipilimumab (IPI) in previously treated patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nivolumab; Discontinuation; Internal medicine; Ipilimumab; Microsatellite instability; Oncology; Adverse effect; Clinical endpoint; Colorectal cancer; Progressive disease; Cancer; Disease; Gastroenterology; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005804506,0.0002855884,0.0005340615,0.0001517762,0.0001994412,0.0003404409,0.0002812028,0.0003290457,0.0008555488],"category_scores_gemma":[0.0003295958,0.000133041,0.0004578302,0.0001954511,0.0001907373,0.0003264181,0.0001879303,0.0006898731,0.0002189332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000510361,"about_ca_system_score_gemma":0.0003079391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006288164,"about_ca_topic_score_gemma":0.002039168,"domain_scores_codex":[0.9998797,0.00004854609,0.000009344425,0.00002393946,0.00001485107,0.00002361437],"domain_scores_gemma":[0.9998159,0.00003599934,0.00005367027,0.00001055427,0.000008089633,0.00007579564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3101714,0.01743605,0.2111849,0.001420103,0.002702988,0.001390266,0.0004818699,0.007625177,0.09450893,0.0001948433,0.004716391,0.3481671],"study_design_scores_gemma":[0.04972907,0.4474271,0.4624073,0.0001567359,0.002212825,0.002237209,0.0001409732,0.006315023,0.0190162,0.0001889484,0.01010884,0.00005987363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966169,0.002275187,0.000140266,0.00008637115,0.00001993551,0.00009036792,0.0001887542,0.00001132381,0.0005710072],"genre_scores_gemma":[0.9981516,0.0006565547,0.0001832935,0.000100592,0.00002747137,0.00006790255,0.0004577929,0.000002756071,0.000352014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008555488,"threshold_uncertainty_score":0.003702998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04304332436701939,"score_gpt":0.381590659690652,"score_spread":0.3385473353236326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}